| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net sales | 95,544 | 51,180 |
| Cost of sales | 68,726 | 36,777 |
| Advertising | 10,387 | 6,046 |
| Other segment expenses | 21,443 | 11,054 |
| Adjusted ebitda | -5,012 | -2,697 |
| Share-based compensation expense (reversal) | 839 | 591 |
| Income taxes | 18 | 9 |
| Depreciation and amortization | 4,561 | 2,283 |
| Interest income (expense), net | -524 | -198 |
| Acquisition/partnership transactions and other items | 0 | 0 |
| Employee severance | 1,319 | 95 |
| Sales tax expense (income) | 0 | - |
| Professional fees | 3,141 | 1,021 |
| Impairment of goodwill and intangible assets | 27,258 | 27,258 |
| Net (loss) income | -42,672 | -34,152 |
| Depreciation and amortization | 4,561 | 2,283 |
| Impairment of goodwill and intangible assets | 27,258 | 27,258 |
| Share based compensation | 839 | 591 |
| Deferred income taxes | 0 | 0 |
| Bad debt expense | 6 | -6 |
| Accounts receivable | -346 | -718 |
| Inventories, net | -1,437 | 2,156 |
| Prepaid income taxes | -36 | 0 |
| Prepaid expenses and other current assets | 1,031 | 1,170 |
| Operating lease right-of-use assets, net | -225 | -112 |
| Accounts payable | -4,445 | -3,523 |
| Sales tax payable | 416 | 127 |
| Accrued expenses and other current liabilities | -23 | -1,287 |
| Lease liabilities | -228 | -113 |
| Deferred revenue | -1,090 | -977 |
| Income taxes payable | -80 | 24 |
| Net cash used in operating activities | -14,445 | -12,271 |
| Purchases of property and equipment | 3,916 | 1,292 |
| Net cash used in investing activities | -3,916 | -1,292 |
| Dividends paid | 23 | 1 |
| Cash paid for tax withholding on net settlement of restricted stock | 238 | 29 |
| Net cash used in financing activities | -261 | -30 |
| Net decrease in cash and cash equivalents | -18,622 | -13,593 |
| Cash and cash equivalents at beginning of period | 54,720 | 54,720 |
| Cash and cash equivalents at end of period | 36,098 | 41,127 |
PETMED EXPRESS INC (PETS)
PETMED EXPRESS INC (PETS)